Bayer subsidiary Monsanto on Tuesday said it would pay $7.25 billion over 21 years to settle class action lawsuits filed by those claiming its Roundup weedkiller caused cancer. File Photo by Bill Greenblatt/UPI | License Photo
Feb. 17 (UPI) -- Officials for Germany-based Bayer have agreed to pay $7.25 billion to settle a class action filed by those who say its Roundup weedkiller caused them or their loved ones to develop cancer.
The proposed settlement would create a fund to pay for existing and future claims filed by those who say the weed killer caused non-Hodgkin lymphoma, which is blood cancer that forms in the body's lymphatic system - most often in the lymph nodes -- and spreads to other organs.
Bayer filed the proposed settlement in the city of St. Louis Circuit Court on Tuesday that also would include a separate Durnell case that is before the Supreme Court.
"The proposed class settlement agreement, together with the Supreme Court case, provides an essential path out of the litigation uncertainty and enables us to devote our full attention to furthering the innovations that lie at the core of our mission: Health for all, Hunger for none," said Bayer Chief Executive Officer Bill Anderson.
